Work

SGLT-2 Inhibitors, GLP-1 Agonists Provide Greater Benefit for Patients With Type 2 Diabetes.

Year: 2024
Type: article
Source: PubMed
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4405658604
FWCI:
Cites:
Cited by:
Related to: 10